- Before
- Answers every deal question by searching the manual and old memos herself, then writes the memo from a blank template.
- Now
- Starts from a cited answer and a drafted memo; spends her time on the judgment in section 4.5 and the reason behind it.
One question, from inbox to signed memo
Northwind Bio closed its purchase of Tamsin Biosciences on Sep 22. On working day 5 of the Q3 close, the deal accountant asks technical accounting what it is and what gets expensed. Here is what happens next, screen by screen, in the working solution.
- 01Wednesday, Oct 7
The quarter’s judgments, on one screen
Dr. Maya Chen · Assistant controller, technical accountingMaya opens the solution on working day 5 of the Q3 close, 21 days before the audit committee. Six memos are open, four of them due to the external auditor by Oct 16. At the top of her list: Sam Patel’s Tamsin question, forwarded at 08:12.
Needs you: “Sam Patel asks about the Tamsin acquisition · Business combination or asset acquisition · forwarded 08:12.”
- 02Asked at 08:12
“Business combination or asset acquisition — and what do we expense?”
Sam Patel · Deal accountantMaya presses Research. The question router labels it ASC 805 and ASC 730, deal Tamsin Biosciences, period Q3 2026. The retriever pulls four policy passages, the Elmstead memo from November 2024 and the July audit committee paper; the standards researcher finds 805-10-55-5A, 805-50-30 and 730-10-25-2(c); the agreement and the valuation report are read at §2.3, §2.5, §6.4 and page 4.
Every step is shown as it runs, with what it found.
- 037 seconds later
A cited answer: asset acquisition
The agentsTMS-118 holds 93.3% of the fair value of the gross assets, and policy treats 90% or more as “substantially all” — so it is an asset acquisition, with no goodwill. The cost is spread by relative fair value, TMS-118 and TMS-207 are expensed to R&D on the close date, and the up-to-$350M milestones are not booked at close. Click a citation and the exact passage opens on the right, highlighted — here, page 4 of the valuation report.
“6 agents · 7.0 s” · “Every sentence cited” · “16 citations · 8 sources” · “Confidence 94%”
- 04Flagged
Policy and practice disagree — and it says so
Practice conflict checkerTamsin holds $12.4M in escrow for its three founders for 18 months. Policy §7.2.6 treats payments that depend on staying as pay for future work; the signed Elmstead memo put a similar payment into the purchase price. Both passages are cited, and acquired R&D shows as a range — $384.5M to $396.4M — until someone decides.
“Tamsin holds $12.4M in escrow for the three founders for 18 months — you decide which view the memo takes.”
- 05One click
“Draft the position memo”
Memo drafterMaya drafts M-311 straight from the answer. Nine facts come out of the agreement and the valuation report, the memo is written in house template v4 — eight sections and a journal entry — and the citation verifier checks every citation. One thing is left for a person: the founder retention.
Judgment finder: “1 decision for you: founder retention ($12.4M).”
- 06Section 4.5
The judgment, put to her with the numbers
Dr. Maya Chen · PreparerOption A follows policy §7.2.6: $384.5M of acquired R&D in Q3, plus $12.4M of compensation over 18 months ($0.2M in Q3). Option B follows the Elmstead precedent: $396.4M, no separate charge, recorded as a policy exception for the committee. Maya picks A and her reason goes on the record with her name and the time.
“The agents do not decide judgments — pick the view the memo takes, and your reason is recorded with your name and the time.”
- 07Written after the decision
Alternatives, conclusion and the journal entry
Memo drafterSections 5 to 7 are written from her choice: the business combination view and capitalising TMS-118 rejected with reasons, the conclusion, the financial statement impact and disclosure, and the journal entry dated Sep 22, 2026 that ties to $431.4M. The memo moves to v0.3 with 21 citations from 8 sources, all verified.
- 08Above $100M
Two dated signatures, because of the size
Priya Raman · Corporate controllerM-311 is over $100M of impact, so it needs the corporate controller and the chief accounting officer. Signing locks the version; any later change creates a new one. The meaning — “Approved as management’s position for Q3 2026” — and the time go to the audit trail with each signature.
- 09Signed · Oct 7
Signed the same morning, nine days before the auditor’s date
Ruth Adeyemi · Chief accounting officerPriya signs v1.0 and Ruth co-signs. The activity trail shows every step from the cited answer at 09:14 to both signatures at 09:16 — who did it, agent or person, and what changed. The memo is ready to share with the external auditor, due Oct 16.
- 10Before the policy committee
The conflict becomes a policy gap
Dr. Maya Chen · Technical accountingThe founder-retention conflict is logged as gap G-1, High, with the policy text and what the Elmstead memo did side by side. It sits with four others — a Larkspur presentation conflict, a pre-launch inventory conflict, a manual silent on priority review vouchers and lease wording that predates the 2019 standard. Each can be drafted as a policy update for the committee, or dismissed with a reason.